Decide at what price you'd be comfortable buying and we'll help you stay ready.
Olin’s history shows earnings and margins that swing with chemical-market conditions and plant utilization, while its manufacturing base requires ongoing capital spending. Operating cash flow can diverge from net income because of noncash depreciation and working-capital timing, against a material debt load.
The latest quarter returned to positive net income and free cash flow, but trailing operating income and net income remained negative. That is a near-term recovery within an uneven earnings cycle, not yet evidence that the underlying financial pattern has changed.
Whether quarterly operating income remains positive as Freeport VCM operations normalize and Chlor Alkali and Vinyls results recover.
| Metric | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 5.6B | 6.3B | 6.9B | 6.1B | 5.8B | 8.9B | 9.4B | 6.8B | 6.5B | 6.8B | |
| (4.9B) | (5.5B) | (5.9B) | (5.4B) | (5.4B) | (6.6B) | (7.2B) | (5.6B) | (5.8B) | (6.3B) | |
| 615.7m | 722m | 1B | 666m | 383.4m | 2.3B | 2.2B | 1.2B | 767.7m | 526m | |
| (325.5m) | (368.3m) | (418.8m) | (412.5m) | (422.1m) | (416.9m) | (390.6m) | (406.4m) | (407.7m) | (462.8m) | |
| (336.1m) | (371.6m) | (425.2m) | (412.9m) | (422m) | (416.9m) | (375.6m) | (386.7m) | (390.1m) | (444m) | |
| — | — | — | — | — | — | (18.3m) | (20m) | (18.4m) | (19.3m) | |
| 10.6m | 3.3m | 6.4m | 400k | (100k) | — | 3.3m | 300k | 800k | 500k | |
| 290.2m | 353.7m | 594.2m | 253.5m | (38.7m) | 1.9B | 1.8B | 782.8m | 360m | 63.2m | |
| (198.3m) | (212m) | (266.7m) | (246.2m) | (288.2m) | (347.8m) | (141.7m) | (176.8m) | (180.8m) | (187m) | |
| 195.6m | 220.4m | 241.1m | 240.6m | 288.7m | 348m | 143.9m | 181.1m | 184.5m | 188.3m | |
| (170.9m) | (58.9m) | 88.1m | (71.7m) | (708m) | (24.3m) | (11.3m) | (70.7m) | (63.5m) | (57.9m) | |
| 44.8m | 34.4m | 21.7m | 27.5m | 14.9m | 35.7m | 38.7m | 24m | 26m | 20.6m | |
| (34.2m) | 117.2m | 437.3m | (36.9m) | (1B) | 1.5B | 1.7B | 559.3m | 141.7m | (161.1m) | |
| 30.3m | (5.6m) | (109.3m) | 25.6m | 50.1m | (242m) | (349.1m) | (107.3m) | (36.7m) | 60m | |
| (3.9m) | 111.6m | 328m | (11.3m) | (969.9m) | 1.3B | 1.3B | 452m | 105m | (101.1m) | |
| — | — | — | — | — | — | — | 8.2m | 3.6m | 600k | |
| (3.9m) | 549.5m | 327.9m | (11.3m) | (969.9m) | 1.3B | 1.3B | 460.2m | 108.6m | (100.5m) | |
| (0.02) | 3.26 | 1.95 | (0.07) | (6.14) | 7.96 | 8.94 | 3.57 | 0.91 | (0.88) |
Alpha Spread
Preferences
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
New to Alpha Spread? Create free account
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more